CXCL11 (Interferon-Inducible T-Cell Alpha Chemoattractant) and Interleukin-18 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Methylprednisolone.

MLA

Szczuciński, Adam, et al. “CXCL11 (Interferon-Inducible T-Cell Alpha Chemoattractant) and Interleukin-18 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Methylprednisolone.” European Neurology, vol. 58, no. 4, Nov. 2007, pp. 228–32. EBSCOhost, https://doi.org/10.1159/000107945.

APA

Szczuciński, A., Kalinowska, A., & Losy, J. (2007). CXCL11 (Interferon-Inducible T-Cell Alpha Chemoattractant) and Interleukin-18 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Methylprednisolone. European Neurology, 58(4), 228–232. https://doi.org/10.1159/000107945

Chicago

Szczuciński, Adam, Alicja Kalinowska, and Jacek Losy. 2007. “CXCL11 (Interferon-Inducible T-Cell Alpha Chemoattractant) and Interleukin-18 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Methylprednisolone.” European Neurology 58 (4): 228–32. doi:10.1159/000107945.